ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0829

Epstein-Barr Virus Infection Triggers Hyperinflammation and Cytokine Storm in Healthy Children

Kailey Brodeur1, Meng Liu2, Rachel Weng2, Evan Hsu2, Lauren Henderson3, Fatma Dedeoglu2, Jane Newburger3, Peter Nigrovic4, Mary Beth Son4 and Pui Lee5, 1Boston Children's Hospital, Cumberland, RI, 2Boston Children's Hospital, Boston, MA, 3Boston Children's Hospital, Watertown, MA, 4Boston Children's Hospital, Brookline, MA, 5Boston Children's Hospital, Newton, MA

Meeting: ACR Convergence 2024

Keywords: cytokines, Infection, Inflammation, macrophage activation syndrome, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: Pediatric Rheumatology – Basic Science

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: Epstein-Barr virus (EBV) is common pathogen responsible for infectious mononucleosis but also triggers hemophagocytic lymphohistiocytosis (HLH). This variation in the immune response to EBV is unexplained.

Methods: We recruited 352 children who presented to the emergency room with fever for ≥ 3 days. We performed immune profiling on 110 cases with confirmed viral infections using Olink proximity extension assay and flow cytometry. We compared the findings with cases of HLH (n=8), macrophage activation syndrome (MAS; n=18), Kawasaki disease (KD; n=20), and multisystem inflammatory syndrome in children (MIS-C; n=17).

Results: We studied 110 otherwise healthy children with confirmed viral infections, including EBV, adenovirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus, parainfluenza virus, and respiratory syncytial virus (RSV; Figure 1A). Using Olink proximity assay to profile 45 proinflammatory mediators, we found that acute EBV infection uniquely triggered high levels of multiple cytokines (IL-18, IL-27, tumor necrosis factor, and lymphotoxin alpha) and IFN-γ-induced chemokines (CXCL9 and CXCL11; Figure 1B). The pattern of cytokine and chemokine production are similar to the cytokine storm associated with HLH / MAS, but less consistent with the findings in KD and MIS-C (Figure 1C-D). Flow cytometry analysis revealed that CD38+HLA-DR+ T lymphocytes, which are pathogenic cells responsible for IFN-γ production in HLH / MAS, are vastly expanded in patients with acute EBV infection (Figure 2A), but not other viral infections. Cell sorting and morphology analysis identified CD38+HLA-DR+ T cells as atypical lymphocytes that are classically associated with EBV infection (Figure 2B).

Conclusion: These findings place acute EBV infection in the cytokine storm spectrum and inform both the unique clinical presentation of this disease and its connection to HLH.

Supporting image 1

Figure 1. Immune profiling of common viral infections in children. A) Schematic illustrating the study groups and identification of viral pathogens among patients with confirmed viral infection. B) Cytokine and chemokine levels quantified by Olink proximity extension assay. Comparison groups included healthy controls (n=15), and patients with adenovirus (n=28), EBV (n=19), RSV (n=18), SARS-CoV_2 (n=13), influenza virus (n=12), or parainfluenza virus (n=7) infection. Dotted line indicates upper limit of detection. P-value from Kruskal-Wallis test is indicated. # indicates p < 0.05 compared to all other groups after adjustment for multiple comparisons by Dunn’s test. C-D) Radar plots illustrating the median expression percentile of key cytokines (panel C) and chemokines (panel D) in healthy controls and patients with EBV, MAS, HLH, non-EBV viral infections, MIS-C or KD. The expression level of each analyte was normalized based on the percentile relative to the entire dataset and the median value of each group is plotted. The EBV group (green dotted line) is displayed in each plot to allow comparison to other groups.

Supporting image 2

Figure 2. Expansion of CD38+HLA-DR+ T cells in acute EBV infection. A) Representative flow cytometry plot of CD38+HLA-DR+ T cells (as percentage of CD4+ and CD8+ T lymphocytes) in healthy controls, and patients with EBV infection, HLH or MAS. B) Representative images and cell size quantification of sorted CD38+HLA-DR+ T cells and CD38-HLA-DR- T cells within the CD4+ and CD8+ T lymphocyte populations from a patient with EBV infection. Mann Whitney U test was used for comparison. * p<0.0001.


Disclosures: K. Brodeur: None; M. Liu: None; R. Weng: None; E. Hsu: None; L. Henderson: Adaptive Biotechnologies, 5, Bristol-Myers Squibb(BMS), 5, Pfizer, 1, Sobi, 2; F. Dedeoglu: UpToDate, 9; J. Newburger: None; P. Nigrovic: American Academy of Pediatrics, 9, Bristol-Myers Squibb(BMS), 5, Century Therapeutics, 2, Edelweiss Immuno, 8, Fresh Tracks Therapeutics, 2, Merck/MSD, 2, Monte Rosa Therapeutics, 2, Novartis, 2, Pfizer, 2, 5, Qiagen, 2, Sobi, 2, UpToDate, 9; M. Son: None; P. Lee: None.

To cite this abstract in AMA style:

Brodeur K, Liu M, Weng R, Hsu E, Henderson L, Dedeoglu F, Newburger J, Nigrovic P, Son M, Lee P. Epstein-Barr Virus Infection Triggers Hyperinflammation and Cytokine Storm in Healthy Children [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/epstein-barr-virus-infection-triggers-hyperinflammation-and-cytokine-storm-in-healthy-children/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epstein-barr-virus-infection-triggers-hyperinflammation-and-cytokine-storm-in-healthy-children/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology